Klinikum Fulda gAG — Clinical Trial Site

11 Registered trials

3 Currently recruiting

Organisation

Klinikum Fulda gAG

Location

Fulda, Germany

Identifier

ORG-100047121

Address

Pacelliallee 4, Ziehers-Sued, 36043, Germany

Departments

Herz-Thorax-Zentrum Fulda, Medizinische Klinik V, Pneumologie
Innere Medizin und Hämatologie und internistische Onkologie
Klinisches Studienzentrum GmbH
Klinisches Studienzentrum, Klinik für Neurologie
Medizinische Klinik II
Onkologie
Radioonkologie Strahlentherapie
Tumorklinik, MVZ Osthessen
Universitätsmedizin Marburg - Campus Fulda, Medizinische Klinik III

Clinical trials at this site (11)

Search interface

PREFer Recruiting

2024-520138-31-00 Early-stage favorable classic Hodgkin lymphoma 4 2026-06-01
Study of Targeted Therapies for the Treatment of Adult Participants with Moderate to Severe Crohn’s Disease Recruiting

2024-513009-30-00 Moderate to Severe Crohn’s Disease 4 2024-11-21
A multicentre, randomized trial in adults with de novo Philadelphia-Chromosome positive acute lymphoblastic leukemia to assess the efficacy … Recruiting

2024-517966-40-00 Acute lymphoblastic leukemia (ALL), de novo, Ph/BCR::AB 4 2023-07-13
A Phase 3 Placebo-controlled Study of Milvexian after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Ended

2022-501176-26-00 Acute Ischemic Stroke and High-Risk Transient Ischemic 5 2023-08-04
Multicenter, prospective, double-blind, randomized, three-armed, placebo-controlled study of long-term therapeutic transfer of encapsulated … Ended

2024-517132-22-00 active ulcerative colitis 5 2023-01-26
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined… Ended

2024-511577-29-01 intermediate and high-risk rectal cancer 5 2020-03-13
A randomized phase III trial assessing the benefit of the addition of isatuximab to lenalidomide / bortezomib / dexamethasone (RVd) inductio… Ended

2024-513464-26-00 Multiple Myeloma 5 2018-10-18
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
Phase 2 Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) Ended

2023-504825-38-00 Lupus Nephritis (LN) Immunoglobulin A Nephropathy (IgAN 4 2022-04-15
CIRCULATE Ended

2023-506715-18-00 colon cancer stage II, rectal cancer stage II 5 2019-12-04
HD21 Ended

2024-518022-33-00 Advanced Stage of Hodgkin Lymphoma 5 2016-07-15